Risponz/Risponz 1/Risponz 2/Risponz 3 Indications/Uses

Risponz 1/Risponz 2/Risponz 3: For the treatment of schizophrenia and other psychoses and in the short‑term treatment of acute manic or mixed episodes associated with bipolar disorder, and for the treatment of irritability associated with autistic disorder.
Risponz: For the treatment of schizophrenia.
For the treatment of moderate to severe manic episodes associated with bipolar disorder.
For the short-term symptomatic treatment (up to six weeks) of persistent aggression in conduct disorder in children from the age of five years and adolescents with sub-average intellectual functioning or mental retardation diagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviors require pharmacological treatment. Pharmacological treatment should be an integral part of a more comprehensive treatment program, including psychosocial and educational intervention. It is recommended that risperidone be prescribed by a specialist in child neurology and child and adolescent psychiatry or physicians well familiar with the treatment of conduct disorder of children and adolescents.